Gender differences in hepatitis C virus incidence in and out of opioid agonist treatment among people who inject drugs in Montréal, Canada, March 2011-March 2024
{{output}}
Background: Some evidence suggests the benefits of opioid agonist therapy (OAT) in preventing hepatitis C virus (HCV) acquisition are stronger in men than women. However, existing analyses have used crude OAT exposure measures. W... ...
